I finally listened to the CCFirst off I will admit every time I listen to Tripp talk part of me wants to believe him and trust him. Again I think its the tone of his voice. If I had not been an investor and had known of all the missed promises and play on words that were never backed up I'd want to invest big time into this play after listening to this.
1. He says telehealth will not be 50% and brick and motar will be 50% but then says telethealth has made it possible for them to talk with countries all over the world. So here is the latest thing that no one can confirm and is designed to make Stage look good when all this could mean is that someone called and left a message with someone in another country. Who would that even be? Again no facts, no diving into it more just more BS.
2. He says using telehealth they have patients in new zealand and austrailia and india and so on. Again nothing to quantify this. Techanical "patients" could mean 2! He doesnt even have to be that accurate. Just hundreds or thousands or tens I dunno. More mystery BS thats all it is.
3. They make as much with TREAT as they do with Aristotle but with TREAT it continues. Any numbers or facts to support this or again should investors just take his word for it? Everyone here knows the answer to that.
4. He says Aristotle does more than cancer. It does cardiovasular, auto immune, etc. Yet never a NR on that or any facts to support that. Have they even proven this in house or are they just in the "if we say it enough its a fact" frame of mind. What this means is there is no way for them to support this statement and their like "forward looking statements" clause at the start prevents them from having to prove it.
5. says their system is "fully validated". If so whey dont they get some more independent companies to validate it as well. Wouldnt that spread the word even quicker and 100% prove they have the best test. one of the Johnnys has been pointing this out today.
6. He talks about a "new deeper" test that will distinquish colon cancer more. I guess we know what NR they will release when they do the next RS or PP.
7. Talking with a hospital group in Toronto. sure sounds a lot like large health care provider mumbo jumbo all over again. Again no names, no proof, likely wont hear any of that info ever just as before.
8. He mentioned Echelon again I guess they are still around. No mention of Claus and the one analyst they had that they made look like an idiot last year with blowing his expectation out of the water. What a joke that was.
9. Matt says they track how many tests they do and how many forms are filled out and this and that. What not tell people what they want to hear. How many aristotle tests last quarter. How many covid tests last quarter. They have the data!
10. Tripp says margins will improve because they have better margins on cancer testing than that of covid tests. Um pretty sure you need to actually have customers to do those tests to make any money and there is no denying that covid was a bigger draw to them than cancer has been in the years since colonsentry
No further questions in queu. I bet there were a lot of questions just no cookie cutter BS questions though and they were told not to read all the questions.